Generating evidence for optimal market access – an Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health

Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. They talk about current dynamics in the healthcare industry and the challenges of generating evidence for optimal market access. Continue Reading

Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD

Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossie 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes. Continue Reading

Closing Gaps in Real-World Evidence through Data Linkage

Interview with Dr. Kevin Haynes, Principal Scientist, HealthCore-NERI. Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Kevin Haynes, Principal Scientist at HealthCore-NERI, to discuss closing gaps in real-world evidence through data linkage. The mission of HealthCore-NERI is to… Continue Reading

Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence

Interview with Flora Sandra Siami, MPH. Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore-NERI. Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Flora Sandra Siami, MPH, Vice President of Clinical Research, Regulatory Affairs, and Quality… Continue Reading